Following recent public reaction to the price of epinephrine auto-injector pens, known as “epi-pens,” and the desire for an affordable alternative, CVS Health intends to market authorized generic version two-packs for $109.99 apiece. Read More »
A recent study has shown that using acetaminophen, an ingredient commonly found in painkillers, over a long period of time leads to an increased risk of hearing loss in adults. Read More »
Mylan CEO Heather Bresch presented at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco. Read More »
The European Commission has granted Gilead Sciences Inc. marketing authorization for Vemlidy, a drug used in the treatment of people suffering from chronic Hepatitis B infections. Read More »
The U.S. Food and Drug Administration recently approved a license application for Mylan Biotechnology, in collaboration with Biocon, for the use of biosimilar tratuzumab in the treatment of breast cancer. Read More »
Gilead Sciences Inc., has awarded more than $22 million in grants to help fund HIV cure programs. Read More »
The Centers for Medicare and Medicaid Services hit a snag last week in seeking approval of a proposal that requires hospitals to have antimicrobial stewardship programs participating in Medicare and Medicaid programs. Read More »
Results from a November study have raised concerns about how pharmacists substitute generic medications for their name brand counterparts. Read More »
A new trend in communications is on the verge of creating a health care revolution, according to one rehabilitation clinic spokesperson. Read More »
The Centers for Disease Control and Prevention have released new resources to encourage pharmacists to take a more active role in the management of hypertension among their patients. Read More »
Ovarian cancer patients who have a sensitivity to chemotherapy will soon have another option to treat their disease as the U.S. Food and Drug Administration has approved Avastin as an alternative to or supplement for chemotherapy. Read More »
A recent study has shown that medical home care model as increased overall primary care of patients, and has reduced overall health care cost. Read More »
Biotech group Genentech scored a big victory as the U.S. Food and Drug Administration has granted a priority review of the company’s newest cancer-treating drug, Tecentriq. Read More »
The U.S. Food and Drug Administration has approved the use of Lucentis, created by biotech company Genentech, for people suffering with severe nearsightedness. Read More »
The public relations departments at American pharmaceutical manufacturers can’t be too pleased about the results of a new Harris Poll out this week that shows only nine percent of U.S. consumers believe “pharmaceutical and biotechnology companies put patients over profits.” Read More »
Two pharmaceutical giants — Sanofi and Regeneron — face a forced marketing shutdown of a high-priced cholesterol medication following a decision recently handed down by a U.S. District Court in Delaware ruling patent infringement of another medication. Read More »
Mylan N.V, a major distributor of over the counter medications, has acquired popular cold medication Cold-Eeze from ProPhase Labs Inc. Read More »
The U.S. Food and Drug Administration has approved Sangamo BioSciences Inc.'s Investigational New Drug Application for the SB-525 gene therapy program for patients with hemophilia A. Read More »
Custopharm Inc., a U.S. producer of generic injectable devices, has acquired two Paragraph IV abbreviated new drug application products from Perrigo Co. PLC. Read More »
The U.S. Food and Drug Administration granted orphan drug designation to Alexion Pharmaceuticals for ALXN1210, a drug for treating patients with paroxysmal nocturnal hemoglobinuria. Read More »
Alerts Sign-up
